Patritumab - CAS 1262787-83-6

Patritumab (U3-1287) is an anti-HER3 monoclonal antibody with potential antitumor activity and inhibits phosphorylation of EGFR, HER2, HER3, ERK, and AKT.Patritumab promotes apoptosis and inhibits proliferation in non-small cell lung cancer.

Akt, PARP, ERK, HER, EGFR, Survivin

Chromatin/Epigenetic, Tyrosine Kinase/Adaptors, JAK/STAT signaling, PI3K/Akt/mTOR signaling, DNA Damage/DNA Repair, Angiogenesis, MAPK, Apoptosis, Cytoskeletal Signaling

1262698

0.982

-20°C

Ice Packs

Inhibitory Antibodies